Pear Bio Secures $14 Million Series A Funding to Advance Predictive Cancer Treatment
Pear Bio, a techbio startup dedicated to enhancing the effectiveness of cancer drug treatments, has successfully raised $14 million in a Series A funding round led by Octopus Ventures. Hoxton Ventures, Crista Galli Ventures, SOSV, Fly Ventures, and Compound Ventures also participated in the funding round. The company is among several European techbio startups that … Read more